News News Select Year All Years 2026 (22) 2025 (34) 2024 (29) 2023 (30) 2022 (33) 2021 (27) 2020 (34) 2019 (32) 2018 (42) 2017 (35) 2016 (43) 2015 (53) 2014 (26) 2013 (21) 2012 (16) 2011 (6) 2010 (4) 2009 (5) 2007 (1) 2006 (1) Search News Found 494 Results Page 32 of 50« First«...1020...3031323334...4050...»Last » March 5, 2017 Data at AAAAI 2017 Show Lasting Response and Favorable Safety Profile of Investigational Agent, Viaskin Peanut, Throughout Three Years of Treatment of Peanut Allergic Children March 1, 2017 DBV Technologies to Attend Upcoming Investor Conferences February 20, 2017 DBV Technologies Reports December 31, 2016 Cash Position February 10, 2017 DBV to Present Data at the 2017 AAAAI Meeting Highlighting the Therapeutic Potential of EPIT® February 3, 2017 DBV Technologies Announces Completion of Enrollment of Phase IIA Study of Viaskin Milk for the Treatment of Pediatric Eosinophilic Esophagitis January 26, 2017 DBV Technologies to Present at the LEERINK Partners 6th Annual Global Healthcare Conference January 9, 2017 DBV Technologies Announces Financial Calendar 2017 January 4, 2017 DBV Technologies Presents its Half-year Statement of the Liquidity Contract November 17, 2016 DBV Technologies, BioNet-Asia and Geneva University Hospitals Complete Dosing in First Cohort of Phase I Study of Viaskin rPT for Booster Vaccination Against Pertussis November 12, 2016 DBV Technologies Announces Poster Presentations at the 2016 American College of Allergy, Asthma, and Immunology Meeting Page 32 of 50« First«...1020...3031323334...4050...»Last »